Jena, Germany

Thomas Riemer

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2009-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Thomas Riemer: Innovator in Neurovascular Research

Introduction

Thomas Riemer is a notable inventor based in Jena, Germany. He has made significant contributions to the field of neurovascular research, particularly through his innovative methods and devices for examining the eye. With a total of five patents to his name, Riemer has established himself as a key figure in advancing medical technology.

Latest Patents

Riemer's latest patents include a method and device for examining the neurovascular coupling at the eye of a patient. This invention utilizes an imaging method to record an image sequence of the fundus of the eye, allowing for the assessment of vessel responses to stimulation. Another significant patent is a device and method for examining the retinal vascular endothelial function. This invention employs a fundus camera to stimulate the retinal vessels with flicker light, enhancing the quality of imaging and patient comfort.

Career Highlights

Throughout his career, Thomas Riemer has worked with companies such as Imedos Systems GmbH and Imedos GmbH. His work has focused on developing technologies that improve the understanding of vascular functions in the eye, contributing to better diagnostic methods in ophthalmology.

Collaborations

Riemer has collaborated with notable professionals in his field, including Walthard Vilser and Martin Skorsetz. These partnerships have furthered his research and development efforts, leading to advancements in medical imaging and neurovascular studies.

Conclusion

Thomas Riemer's contributions to neurovascular research through his patents and collaborations highlight his role as an innovator in the medical field. His work continues to impact the understanding and treatment of eye-related vascular conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…